14:15 – 14:35
StethX Acoustic Wearable Patch for Monitoring and Diagnosis of Cardio-Pulmonary Conditions
Cardiovascular and respiratory diseases are significant public health issues affecting millions of individuals globally and burdening healthcare systems tremendously. StethX has developed a smart, easy-to-use and low-profile wearable patch for accurate detection, analysis and quantification of heart sounds and respiratory abnormalities by capturing mechano-acoustic signals emanated from heart and lung. In this talk, an overview of the capabilities of the patch for longitudinal monitoring and at-home use will be discussed and the latest clinical results from the patch will be presented.
Farrokh Ayazi, Ph.D.
StethX Microsystems
Farrokh Ayazi is the Founder and CEO of StethX Microsystems, a spin-off of the Georgia Tech Integrated MEMS Laboratory that is commercializing advanced wearable patches for cardiopulmonary applications. He received the B.S. degree from the University of Tehran, Iran, in 1994, and the M.S. and Ph.D. degrees from the University of Michigan, Ann Arbor, in 1997 and 2000, respectively, all in electrical engineering. Dr. Ayazi is the Regents Entrepreneur and Ken Byers Professor in Microsystems at the Georgia Institute of Technology, where his main research interest lies in the area of integrated Micro/Nano-Electro-Mechanical-Systems (MEMS and NEMS), with a focus on high-Q acoustic resonators and advanced inertial sensors. Dr. Ayazi was the co-founder and CTO of Qualtré, a spin-out of his research laboratory that commercialized bulk acoustic wave silicon gyroscopes for high precision applications, which was acquired by Panasonic in 2016. Dr. Ayazi is a fellow of the IEEE, has authored over 300 refereed technical and scientific articles, and holds more than 60 patents. He was the general chair of the IEEE Micro-Electro-Mechanical-Systems conference in 2014, held in San Francisco, CA.
Company Profile
StethX is a start-up company located in Atlanta, GA commercializing a proprietary wearable sensor technology that enables remote and long-term monitoring of cardio-pulmonary conditions with high fidelity.
